These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
¨
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
Delaware
|
|
20-5657551
|
|
(State or other jurisdiction of
incorporation of organization)
|
|
(I.R.S. Employer
Identification Number)
|
|
Large accelerated filer
|
|
¨
|
Accelerated filer
|
|
¨
|
|
Non-accelerated filer
|
|
¨
|
Smaller reporting company
|
|
x
|
|
(Do not check if a smaller reporting company)
|
|
|
Emerging growth company
|
|
¨
|
|
|
|
|
|
Page
|
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
Condensed Consolidated Balance Sheets as of March 31, 2017 and December 31, 2016
|
|
|
|
|
|
|
|
Condensed Consolidated Statements of Operations for the Three-Month Periods Ended March 31, 2017 and 2016
|
|
|
|
|
|
|
|
Condensed Consolidated Statements of Comprehensive Loss for the Three-Month Periods Ended March 31, 2017 and 2016
|
|
|
|
|
|
|
|
Condensed Consolidated Statements of Cash Flows for the Three-Month Periods Ended March 31, 2017 and 2016
|
|
|
|
|
|
|
|
Notes to Condensed Consolidated Financial Statements
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
March 31,
2017 |
|
December 31,
2016 |
||||
|
|
|
|
|
|
||||
|
ASSETS
|
|
|
|
|
||||
|
Current assets:
|
|
|
|
|
||||
|
Cash and cash equivalents
|
|
$
|
10,203
|
|
|
$
|
11,826
|
|
|
Restricted cash
|
|
6,020
|
|
|
6,020
|
|
||
|
Marketable securities
|
|
11
|
|
|
9
|
|
||
|
Accounts receivable, net of allowance for doubtful accounts of $1,581 and $1,569, respectively
|
|
15,363
|
|
|
18,790
|
|
||
|
Inventories, net
|
|
1,244
|
|
|
1,012
|
|
||
|
Prepaid expenses and other current assets
|
|
2,796
|
|
|
2,891
|
|
||
|
Income taxes receivable
|
|
72
|
|
|
87
|
|
||
|
Total current assets
|
|
35,709
|
|
|
40,635
|
|
||
|
Property and equipment, net of accumulated depreciation of $24,942 and $24,542, respectively
|
|
10,362
|
|
|
10,920
|
|
||
|
Goodwill
|
|
2,116
|
|
|
2,116
|
|
||
|
Other intangible assets, net of accumulated amortization of $7,765 and $7,257, respectively
|
|
3,283
|
|
|
3,451
|
|
||
|
Other assets
|
|
684
|
|
|
666
|
|
||
|
Total assets
|
|
$
|
52,154
|
|
|
$
|
57,788
|
|
|
LIABILITIES AND SHAREHOLDERS' EQUITY
|
|
|
|
|
||||
|
Current liabilities:
|
|
|
|
|
||||
|
Accounts payable
|
|
4,480
|
|
|
6,303
|
|
||
|
Accrued liabilities:
|
|
|
|
|
||||
|
Employee compensation
|
|
1,170
|
|
|
1,390
|
|
||
|
Other accrued liabilities
|
|
5,169
|
|
|
6,357
|
|
||
|
Total current liabilities
|
|
10,819
|
|
|
14,050
|
|
||
|
Other liabilities
|
|
365
|
|
|
346
|
|
||
|
Total liabilities
|
|
11,184
|
|
|
14,396
|
|
||
|
COMMITMENTS AND CONTINGENCIES (Note 10)
|
|
|
|
|
||||
|
Shareholders’ equity:
|
|
|
|
|
||||
|
Common stock, $.01 par value, 40,000,000 shares authorized, 23,914,256 and 23,800,924 shares issued, and 23,533,883, and 23,446,035 shares outstanding, respectively
|
|
239
|
|
|
238
|
|
||
|
Additional paid-in capital
|
|
137,369
|
|
|
137,380
|
|
||
|
Accumulated deficit
|
|
(94,026
|
)
|
|
(91,520
|
)
|
||
|
Accumulated other comprehensive loss
|
|
(1,451
|
)
|
|
(1,568
|
)
|
||
|
Nil coupon perpetual loan notes
|
|
76
|
|
|
76
|
|
||
|
Treasury stock, at cost
|
|
(1,237
|
)
|
|
(1,214
|
)
|
||
|
Total shareholders’ equity
|
|
40,970
|
|
|
43,392
|
|
||
|
Total liabilities and shareholders’ equity
|
|
$
|
52,154
|
|
|
$
|
57,788
|
|
|
|
|
Three Months Ended
March 31, |
||||||
|
|
|
2017
|
|
2016
|
||||
|
Revenues
|
|
$
|
8,491
|
|
|
$
|
17,822
|
|
|
Costs and expenses:
|
|
|
|
|
||||
|
Cost of sales
|
|
4,769
|
|
|
11,774
|
|
||
|
Selling, general and administrative
|
|
5,154
|
|
|
7,162
|
|
||
|
Restructuring charge
|
|
61
|
|
|
317
|
|
||
|
Research and development
|
|
1,014
|
|
|
1,158
|
|
||
|
|
|
10,998
|
|
|
20,411
|
|
||
|
Operating loss
|
|
(2,507
|
)
|
|
(2,589
|
)
|
||
|
Interest income
|
|
3
|
|
|
10
|
|
||
|
Other expense
|
|
(2
|
)
|
|
(263
|
)
|
||
|
Loss before income taxes
|
|
(2,506
|
)
|
|
(2,842
|
)
|
||
|
Income tax benefit
|
|
—
|
|
|
205
|
|
||
|
Net loss
|
|
$
|
(2,506
|
)
|
|
$
|
(2,637
|
)
|
|
Net loss per common share:
|
|
|
|
|
||||
|
Basic
|
|
$
|
(0.11
|
)
|
|
$
|
(0.11
|
)
|
|
Diluted
|
|
$
|
(0.11
|
)
|
|
$
|
(0.11
|
)
|
|
Weighted-average number of common shares outstanding:
|
|
|
|
|
||||
|
Basic
|
|
23,472,000
|
|
|
23,184,000
|
|
||
|
Diluted
|
|
23,472,000
|
|
|
23,184,000
|
|
||
|
|
|
Three Months Ended
March 31, |
||||||
|
|
|
2017
|
|
2016
|
||||
|
Net loss
|
|
$
|
(2,506
|
)
|
|
$
|
(2,637
|
)
|
|
Other comprehensive income:
|
|
|
|
|
||||
|
Foreign currency translation adjustments
|
|
116
|
|
|
429
|
|
||
|
Unrealized gains (losses) from marketable securities, net of tax
|
|
1
|
|
|
(3
|
)
|
||
|
Total other comprehensive income
|
|
117
|
|
|
426
|
|
||
|
Comprehensive loss
|
|
$
|
(2,389
|
)
|
|
$
|
(2,211
|
)
|
|
|
|
Three Months Ended
March 31, |
||||||
|
|
|
2017
|
|
2016
|
||||
|
Operating Activities
|
|
|
|
|
||||
|
Net loss
|
|
$
|
(2,506
|
)
|
|
$
|
(2,637
|
)
|
|
Adjustments to reconcile net loss to net cash used in operating activities:
|
|
|
|
|
||||
|
Depreciation
|
|
405
|
|
|
486
|
|
||
|
Amortization
|
|
205
|
|
|
434
|
|
||
|
Loss on disposal of equipment
|
|
10
|
|
|
1
|
|
||
|
Provision for doubtful accounts, net of recoveries
|
|
—
|
|
|
(99
|
)
|
||
|
Deferred income taxes
|
|
—
|
|
|
(99
|
)
|
||
|
Stock-based compensation, net of forfeitures
|
|
(10
|
)
|
|
461
|
|
||
|
Changes in operating assets and liabilities:
|
|
|
|
|
||||
|
Accounts receivable
|
|
3,525
|
|
|
(3,331
|
)
|
||
|
Inventories
|
|
(26
|
)
|
|
219
|
|
||
|
Prepaid expenses, other current assets and other non-current assets
|
|
108
|
|
|
597
|
|
||
|
Accounts payable
|
|
(1,848
|
)
|
|
(377
|
)
|
||
|
Accrued liabilities and other non-current liabilities
|
|
(1,483
|
)
|
|
(1,243
|
)
|
||
|
Net cash used in operating activities
|
|
(1,620
|
)
|
|
(5,588
|
)
|
||
|
Investing Activities
|
|
|
|
|
||||
|
Purchases of property, equipment and patents
|
|
(97
|
)
|
|
(91
|
)
|
||
|
Proceeds from the sale of equipment
|
|
—
|
|
|
1
|
|
||
|
Net cash used in investing activities
|
|
(97
|
)
|
|
(90
|
)
|
||
|
Financing Activities
|
|
|
|
|
||||
|
Change in restricted cash
|
|
—
|
|
|
(7,020
|
)
|
||
|
Taxes paid on behalf of equity award participants
|
|
(23
|
)
|
|
(53
|
)
|
||
|
Net cash used in financing activities
|
|
(23
|
)
|
|
(7,073
|
)
|
||
|
Effect of exchange rate fluctuations on cash
|
|
117
|
|
|
450
|
|
||
|
Net decrease in cash and cash equivalents
|
|
(1,623
|
)
|
|
(12,301
|
)
|
||
|
Cash and cash equivalents at beginning of period
|
|
11,826
|
|
|
21,684
|
|
||
|
Cash and cash equivalents at end of period
|
|
$
|
10,203
|
|
|
$
|
9,383
|
|
|
|
|
Three Months Ended
|
|||||
|
|
|
2017
|
2016
|
||||
|
Restructuring liability at January 1,
|
|
$
|
309
|
|
$
|
—
|
|
|
Amounts expensed
|
|
61
|
|
317
|
|
||
|
Amounts paid
|
|
(184
|
)
|
(304
|
)
|
||
|
Restructuring liability at March 31,
|
|
$
|
186
|
|
$
|
13
|
|
|
|
|
Three Months Ended
|
|||||
|
|
|
March 31,
|
|||||
|
|
|
2017
|
2016
|
||||
|
Foreign currency translation
|
|
|
|
||||
|
Balance at beginning of period
|
|
$
|
(1,574
|
)
|
$
|
(1,568
|
)
|
|
Other comprehensive loss:
|
|
|
|
||||
|
Foreign currency translation adjustments (1)
|
|
116
|
|
429
|
|
||
|
Balance at end of period
|
|
$
|
(1,458
|
)
|
$
|
(1,139
|
)
|
|
Available-for-sale marketable securities
|
|
|
|
||||
|
Balance at beginning of period
|
|
$
|
6
|
|
$
|
12
|
|
|
Other comprehensive income:
|
|
|
|
||||
|
Net unrealized holding gain (loss) (2)
|
|
1
|
|
(3
|
)
|
||
|
Balance at end of period
|
|
$
|
7
|
|
$
|
9
|
|
|
Total accumulated other comprehensive loss
|
|
$
|
(1,451
|
)
|
$
|
(1,130
|
)
|
|
(1)
|
In all periods presented, there were no tax impacts related to rate changes and no amounts were reclassified to earnings.
|
|
(2)
|
In all periods presented, there were no realized holding gains or losses and therefore no amounts were reclassified to earnings.
|
|
|
|
Three Months Ended
March 31, |
||||
|
|
|
2017
|
|
2016
|
||
|
Basic weighted-average shares
|
|
23,472,000
|
|
|
23,184,000
|
|
|
Conversion of unsecured loan notes
|
|
—
|
|
|
—
|
|
|
Unexercised options and unvested RSUs
|
|
—
|
|
|
—
|
|
|
Diluted weighted-average shares
|
|
23,472,000
|
|
|
23,184,000
|
|
|
|
|
Three Months Ended
March 31, |
|||||
|
|
|
2017
|
2016
|
||||
|
Stock options and restricted stock units, net of forfeited
|
|
$
|
(10
|
)
|
$
|
461
|
|
|
Tax benefit of stock-based compensation expense
|
|
—
|
|
—
|
|
||
|
After-tax effect of stock-based compensation (1)
|
|
$
|
(10
|
)
|
$
|
461
|
|
|
•
|
The first type of award is based on individual performance during the respective calendar year as determined by the Committee based on performance criteria specified in the Agreement. These awards will vest over a
three
year period beginning on the Determination Date. We estimated the fair value of these performance-based RSU awards on the date of the Agreement using the trading price of the Company’s stock and our estimate of the probability that the specified performance criteria will be met. The fair value measurement and probability estimate will be re-measured each reporting date until the Determination Date, at which time the final award amount will be known. For these job performance-based awards, we amortize compensation costs over the requisite service period, adjusted for estimated forfeitures, for each separately vesting tranche of the award.
|
|
•
|
The second type of RSU award contains a targeted number of RSUs to be granted based on the Company’s revenue growth relative to a specified peer group during a period of
two
calendar years. These awards vest
67%
on the second anniversary of the Agreement date and
33%
on the third anniversary of the Agreement date. We estimated the fair value of these performance-based RSU awards on the Agreement date using the trading price of the Company’s stock on the date of determination and our estimate of the probability that the specified performance criteria will be met. For these revenue growth performance-based awards, we amortize compensation costs over the requisite service period, adjusted for estimated forfeitures, for each separately vesting tranche of the award.
|
|
•
|
The third type of RSU award contains a targeted number of RSUs to be granted based on the total shareholder return (TSR) of the Company’s common stock relative to a specified peer group during a period of
two
calendar years. These awards vest
67%
on the second anniversary of the Agreement date and
33%
on the third anniversary of the Agreement date. We estimated the fair value of these market-based RSU awards on the Agreement date using a Monte Carlo valuation methodology and amortize the fair value over the requisite service period for each separately vesting tranche of the award. The principal variable assumptions utilized in valuing these RSUs under this valuation methodology include the risk-free interest rate, stock volatility, and correlations between our stock price and the stock prices of a peer group of companies.
|
|
|
|
Shares
|
|
Weighted Average
Grant Date
Fair Value
|
|||
|
Unvested restricted stock units at January 1, 2017
|
|
1,463,796
|
|
|
$
|
2.82
|
|
|
Granted
|
|
—
|
|
|
—
|
|
|
|
Forfeited
|
|
(200,000
|
)
|
|
3.03
|
|
|
|
Vested
|
|
(113,332
|
)
|
|
4.28
|
|
|
|
Unvested restricted stock units at March 31, 2017
|
|
1,150,464
|
|
|
$
|
2.64
|
|
|
•
|
The Air Pollution Control technology segment includes technologies to reduce NO
x
emissions in flue gas from boilers, incinerators, furnaces and other stationary combustion sources. These include Low and Ultra Low NO
x
Burners (LNB and ULNB), Over-Fire Air (OFA) systems, NO
x
OUT
®
and HERT™ Selective Non-Catalytic Reduction (SNCR) systems, and Advanced Selective Catalytic Reduction (ASCR
™
) systems. Our ASCR systems include ULNB, OFA, and SNCR components, along with a downsized SCR catalyst, Ammonia Injection Grid (AIG), and Graduated Straightening Grid GSG™ systems to provide high NO
x
reductions at significantly lower capital and operating costs than conventional SCR systems. The NO
x
OUT CASCADE
®
and NO
x
OUT-SCR
®
processes are more basic, using just SNCR and SCR catalyst components. ULTRA™ technology creates ammonia at a plant site using safe urea for use with any SCR application. Flue Gas Conditioning systems are chemical injection systems offered in markets outside the U.S. and Canada to enhance electrostatic precipitator and fabric filter performance in controlling particulate emissions.
|
|
•
|
The FUEL CHEM
®
technology segment, which uses chemical processes in combination with advanced CFD and CKM boiler modeling, for the control of slagging, fouling, corrosion, opacity and other sulfur trioxide-related issues in furnaces and boilers through the addition of chemicals into the furnace using TIFI
®
Targeted In-Furnace Injection™ technology.
|
|
•
|
The Fuel Conversion segment represents a new business initiative we commenced in 2014. We acquired intellectual property rights and know-how related to the CARBONITE® fuel conversion process and technology. This process can convert coals of various grades into value-added products that are high in energy content, carbon-rich and less pollutive. This technology has a number of potential applications including certain coal replacement, electric arc furnace (EAF) reductant, ferro-alloy feedstock, absorbent and Hg reduced carbon stock. During 2015 and 2016, we have been testing and developing the engineered carbon products for specific markets. We are in the process of evaluating the commercialization of these product offerings with prospective customers and considering alternatives. We have earned no significant revenue other than for test products from perspective customers for the
three
-months ended
March 31, 2017
and
2016
.
|
|
Three months ended March 31, 2017
|
|
Air Pollution
Control Segment |
|
FUEL CHEM
Segment
|
|
Fuel Conversion Segment
|
|
Other
|
|
Total
|
||||||||||
|
Revenues from external customers
|
|
$
|
4,002
|
|
|
$
|
4,489
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
8,491
|
|
|
Cost of sales
|
|
(2,500
|
)
|
|
(2,269
|
)
|
|
—
|
|
|
—
|
|
|
(4,769
|
)
|
|||||
|
Gross margin
|
|
1,502
|
|
|
2,220
|
|
|
—
|
|
|
—
|
|
|
3,722
|
|
|||||
|
Selling, general and administrative
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(5,154
|
)
|
|
(5,154
|
)
|
|||||
|
Restructuring charge
|
|
—
|
|
|
(61
|
)
|
|
—
|
|
|
—
|
|
|
(61
|
)
|
|||||
|
Research and development
|
|
—
|
|
|
—
|
|
|
(730
|
)
|
|
(284
|
)
|
|
(1,014
|
)
|
|||||
|
Operating income (loss)
|
|
$
|
1,502
|
|
|
$
|
2,159
|
|
|
$
|
(730
|
)
|
|
$
|
(5,438
|
)
|
|
$
|
(2,507
|
)
|
|
Three months ended March 31, 2016
|
|
Air Pollution
Control Segment
|
|
FUEL CHEM
Segment
|
|
Fuel Conversion Segment
|
|
Other
|
|
Total
|
||||||||||
|
Revenues from external customers
|
|
$
|
12,990
|
|
|
$
|
4,832
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
17,822
|
|
|
Cost of sales
|
|
(9,319
|
)
|
|
(2,455
|
)
|
|
—
|
|
|
—
|
|
|
(11,774
|
)
|
|||||
|
Gross margin
|
|
3,671
|
|
|
2,377
|
|
|
—
|
|
|
—
|
|
|
6,048
|
|
|||||
|
Selling, general and administrative
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(7,162
|
)
|
|
(7,162
|
)
|
|||||
|
Restructuring charge
|
|
(195
|
)
|
|
(122
|
)
|
|
—
|
|
|
|
|
|
(317
|
)
|
|||||
|
Research and development
|
|
—
|
|
|
—
|
|
|
(687
|
)
|
|
(471
|
)
|
|
(1,158
|
)
|
|||||
|
Operating income (loss)
|
|
$
|
3,476
|
|
|
$
|
2,255
|
|
|
$
|
(687
|
)
|
|
$
|
(7,633
|
)
|
|
$
|
(2,589
|
)
|
|
|
|
Three Months Ended
March 31, |
||||||
|
|
|
2017
|
|
2016
|
||||
|
Revenues:
|
|
|
|
|
||||
|
United States
|
|
$
|
6,734
|
|
|
$
|
14,430
|
|
|
Foreign
|
|
1,757
|
|
|
3,392
|
|
||
|
|
|
$
|
8,491
|
|
|
$
|
17,822
|
|
|
|
|
March 31,
2017 |
|
December 31,
2016 |
||||
|
Assets:
|
|
|
|
|
||||
|
United States
|
|
$
|
34,483
|
|
|
$
|
37,684
|
|
|
Foreign
|
|
17,671
|
|
|
20,104
|
|
||
|
|
|
$
|
52,154
|
|
|
$
|
57,788
|
|
|
|
|
Three Months Ended
March 31, |
||||||
|
|
|
2017
|
|
2016
|
||||
|
Aggregate product warranty liability at beginning of period
|
|
$
|
159
|
|
|
$
|
268
|
|
|
Net aggregate (benefit) related to product warranties
|
|
—
|
|
|
(109
|
)
|
||
|
Aggregate reductions for payments
|
|
—
|
|
|
—
|
|
||
|
Aggregate product warranty liability at end of period
|
|
$
|
159
|
|
|
$
|
159
|
|
|
a.
|
Exhibits (all filed herewith)
|
||
|
|
|
|
|
|
|
31.1
|
|
Certification of CEO pursuant to Section 302 of Sarbanes-Oxley Act of 2002
|
|
|
|
|
|
|
|
31.2
|
|
Certification of CFO pursuant to Section 302 of Sarbanes-Oxley Act of 2002
|
|
|
|
|
|
|
|
32
|
|
Certification of CEO and CFO pursuant to Section 906 of Sarbanes-Oxley Act of 2002
|
|
|
|
|
|
|
|
101.1
|
|
INSXBRL Instance Document
|
|
|
|
|
|
|
|
101.2
|
|
SCHXBRL Taxonomy Extension Schema Document
|
|
|
|
|
|
|
|
101.3
|
|
CALXBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
|
|
|
|
|
101.4
|
|
DEFXBRL Taxonomy Extension Definition Linkbase Document
|
|
|
|
|
|
|
|
101.5
|
|
LABXBRL Taxonomy Extension Label Linkbase Document
|
|
|
|
|
|
|
|
101.6
|
|
PREXBRL Taxonomy Extension Prevention Linkbase Document
|
|
Date: May 11, 2017
|
By:
|
/s/ Vincent J. Arnone
|
|
|
|
Vincent J. Arnone
|
|
|
|
President and Chief Executive Officer
|
|
|
|
(Principal Executive Officer)
|
|
Date: May 11, 2017
|
By:
|
/s/ David S. Collins
|
|
|
|
David S. Collins
|
|
|
|
Senior Vice President and Chief Financial Officer
|
|
|
|
(Principal Financial Officer)
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|